{
    "Case ID": "015074",
    "Different Crime": [
        {
            "Crime Name": "Patent Infringement Dispute",
            "Crime Type": "Economic_Crimes_or_Fraud-related_Offenses",
            "legal_basis": [
                "Patented Medicines (Notice of Compliance) Regulations"
            ],
            "patent_validity": [
                "invalid due to obviousness"
            ],
            "expert_testimony": [
                "based on prior art and expert testimony"
            ],
            "technical_details": [
                "70 mg weekly alendronate dosage",
                "higher doses of alendronate were known to be safe and effective",
                "increasing dose frequency while reducing administration"
            ],
            "cause_of_action": [
                "Merck sought to extend its market exclusivity by patenting a modified dosing regimen for alendronate"
            ],
            "decision_outcome": [
                "The court dismissed Merck's application"
            ]
        }
    ]
}